Blood coagulation and fibrinolysis in patients with hyperthyroidism

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03344016PMID 12030606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelial Function in Patients with Hyperthyroidism Before and After Treatment with Propranolol and Thiamazol

  2001cited by this paper
• Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects.

  1999cited by this paper
• Impaired release of tissue plasminogen activator from the endothelium in Graves' disease — indicator of endothelial dysfunction and reduced fibrinolytic capacity

  1998cited by this paper
• Increased Plasma Levels of Free Tissue Factor Pathway Inhibitor in Patients with Graves’ Disease

  1998cited by this paper
• Increase by tri-iodothyronine of endothelin-1, fibronectin and von Willebrand factor in cultured endothelial cells.

  1997cited by this paper
• [Study of serum thrombomodulin(TM) levels in patients with hyper- or hypo- thyroidism].

  1997cited by this paper
• Plasma endothelin-1 levels in patients with type II diabetes mellitus

  1996cited by this paper
• The Influence of Insulin, ß-Estradiol, Dexamethasone and Thyroid Hormone on the Secretion of Coagulant and Anticoagulant Proteins by HepG2 Cells

  1995cited by this paper
• Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease

  1995cited by this paper
• Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.

  1995cited by this paper
• Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.

  1995cited by this paper
• Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells.

  1994cited by this paper
• Assessment of endothelial function during oral contraception in women with insulin-dependent diabetes mellitus.

  1994cited by this paper
• Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma.

  1994cited by this paper
• Experimental hypothyroidism increases plasminogen activator inhibitor activity in rat plasma.

  1993cited by this paper
• Elevated plasma levels of VWF:Ag in hyperthyroidism are mediated through beta-adrenergic receptors.

  1993cited by this paper
• Activation of blood coagulation and fibrinolysis in Graves' disease.

  1991cited by this paper
• Features of endothelial dysfunction in early diabetic nephropathy.

  1989cited by this paper
• Thyrotoxicosis, atrial fibrillation, and embolism, revisited.

  1989cited by this paper
• Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment

  1988cited by this paper
• Acquired von Willebrand’s Disease in Hypothyroidism

  1987cited by this paper
• Effect of thyroid hormones on plasma protein concentrations in man.

  1986cited by this paper
• Problems of anticoagulation with warfarin in hyperthyroidism.

  1986cited by this paper
• Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

  1985cited by this paper
• Factor VIII activity in normal volunteers receiving oral thyroid hormone.

  1983cited by this paper
• Factor VIII activity and thyroid function.

  1982cited by this paper
• Arterial embolism in thyrotoxicosis with atrial fibrillation.

  1981cited by this paper
• Coagulation and fibrinolysis in thyroid disease.

  1978cited by this paper
• Blood Coagulation and Fibrinolysis in Thyroid Disease

  1976cited by this paper
• PREDISPOSITION FOR ATOPY OR ALLERGY LINKED TO HL-A

  1975cited by this paper
• The Biological Disappearance Rate of Prothrombin, Factors VII, IX and X from Plasma in Hypothyroidism, Hyperthyroidism, and During Fever

  1963cited by this paper

• Beyond Atrial Fibrillation: A Case of Thyrotoxicosis-Associated Ischemic Stroke in a Young Patient.

  2026cites this paper
• Investigation of hemorheology in patients with hyperthyroidism via blood viscosity, erythrocyte deformability and aggregation

  2025cites this paper
• Thyroid storm-induced cardiovascular complications and modalities of therapy: Up-to-date review

  2025cites this paper
• Unusual chest pain and dyspnea

  2024influential citation
• Evaluation Of New Biomarkers As A Predictor For Thrombosis In Patients with Thyroid Dysfunction

  2024cites this paper
• Massive Cerebral Venous Sinus Thrombosis as an Unexpected Complication of Severe Hyperthyroidism

  2023cites this paper
• Coagulation Profile in Patients with Autoimmune Thyroiditis: A Cross-sectional Exploratory Study

  2023cites this paper
• Cerebral Sinus Vein Thrombosis and Gender: A Not Entirely Casual Relationship

  2023cites this paper
• The Autosomal Short Tandem Repeat Polymorphisms Are Potentially Associated with Cardiovascular Disease Predisposition in the Latin American Population: A Mini Review

  2023cites this paper
• [Two cases of ischemic stroke due to low protein C caused by severe hyperthyroidism].

  2022cites this paper
• Unprovoked Isolated Pulmonary Embolism and Graves’ Disease in a Patient With Dyspnea: A Case Report

  2022cites this paper
• Thyroid hormones and platelet activation in COVID-19 patients

  2022cites this paper
• Cardiac manifestations in hyperthyroidism

  2022cites this paper
• Fluctuations in Thyroid Hormone Levels During Initial Treatment for Differentiated Thyroid Carcinoma are Associated with Changes in Hemostasis: A Prospective Cohort Study

  2022cites this paper
• Platelet abnormalities in autoimmune thyroid diseases: A systematic review and meta-analysis

  2022cites this paper
• Graves Thyrotoxicosis and Cerebral Venous Sinus Thrombosis Causality or Chance Alone

  2021cites this paper
• Evaluation of hemostasis in hyperthyroid cats

  2021cites this paper
• The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease

  2021cites this paper
• Proteomics Profiling of the Urine of Patients with Hyperthyroidism after Anti-Thyroid Treatment

  2021cites this paper
• Thyroid Diseases Are an Underestimated Risk Factor for Cerebral Venous Sinus Thrombosis

  2020cites this paper
• GRAVES HASTALARINDA KARDİYOVASKÜLER RİSK FAKTÖRÜ OLARAK: MPV VE RDW

  2020cites this paper
• The role of von Willebrand factor alterations in thyroid disorders

  2020cites this paper
• Incidence and Mortality of Myocardial Infarction and Stroke in Patients with Hyperthyroidism: A Nationwide Cohort Study in Korea

  2020cites this paper
• Increased risk of venous thromboembolism among patients with hyperthyroidism: a systematic review and meta-analysis of cohort studies.

  2019cites this paper
• Subclinical Hyperthyroidism Could Predict Poor Outcomes in Patients With Acute Ischemic Stroke Treated With Reperfusion Therapy

  2019cites this paper
• Low triiodothyronine syndrome is associated with hemorrhagic transformation in patients with acute ischaemic stroke

  2019cites this paper
• Factor VIII and Thrombosis

  2018cites this paper
• Armour® Thyroid Rage - A Dangerous Mixture

  2018cites this paper
• Cerebral venous sinus thrombosis precipitated by Graves’ disease

  2018cites this paper
• Study on Coagulation Factor VIII and Fibrinogen Levels in Patients with Thyroid Disorders

  2018cites this paper
• Risk of cancer in patients with thyroid disease and venous thromboembolism

  2018cites this paper
• Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders

  2017cites this paper
• Maintaining euthyroidism: fundamentals of thyroid hormone physiology, iodine metabolism and hypothyroidism

  2017cites this paper
• Hemostasis in Overt and Subclinical Hyperthyroidism

  2017influential citation
• Endocrine-related factors and risk of venous thromboembolism

  2017cites this paper
• Trombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de caso

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Thyroid disease and haemostasis : a relationship with clinical implications ?

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Thyroid disease and haemostasis : a relationship with clinical implications ?

  2017influential citation
• Mean Platelet Volume in Graves’ disease: A Sign of Hypermetabolism Rather than Autoimmunity?

  2017cites this paper
• miR-30c may serve a role in endometriosis by targeting plasminogen activator inhibitor-1

  2017cites this paper
• A case of cerebral venous sinus thrombosis secondary to hyperthyroidism

  2017cites this paper
• Manifestation of non-ST elevation myocardial infarction due to hyperthyroidism in an anomalous right coronary artery

  2017cites this paper
• The Hypercoagulable state in Hyperthyroidism is mediated via the Thyroid Hormone β Receptor pathway.

  2016cites this paper
• Measurement of D-Dimer Levels in Hyperthyroidism Patients

  2016cites this paper
• Signal peptide‐CUB‐EGF domain‐containing protein 1 (SCUBE1) levels in patients with overt and subclinical hyperthyroidism: effects of treatment

  2016cites this paper
• Endocrine determinants of haemostasis and thrombosis risk: Focus on thyroid hormone

  2016cites this paper
• VARIATION TENDENCY OF COAGULATION PARAMETERS IN DIFFERENT HYPOTHYROIDISM STAGES.

  2016cites this paper
• A Case of Cerebral Venous Thrombosis in a Patient with Graves' Disease

  2016cites this paper
• The effects of pituitary and thyroid disorders on haemostasis: potential clinical implications

  2016cites this paper
• THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR ( SSRI ) TREATMENT ON MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER ( MDD ) PATIENTS

  2016cites this paper
• Chapter 82 – Graves’ Disease

  2016cites this paper
• Pulmonary Embolism in Case of Hyperthyroidism: A Rare Case Report. -

  2016cites this paper
• Thyroid function, assessed by thyroid stimulating hormone, and future risk of venous thromboembolism -The Tromsø study

  2016cites this paper
• Ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress.

  2015cites this paper
• Effects of subclinical hypothyroidism on bone mineral density and cardiometabolic risk : genetic and immune influences

  2015cites this paper
• Non Atrial Fibrillation related Central Retinal Artery Occlusion (CRAO) in Hyperthyroidism: A Case Report

  2015cites this paper
• RARE CASE REPORT OF ACUTE MYOCARDIAL INFARCTION AS AN INITIAL PRESENT AT ION OF THYROTOXICOCIS

  2015cites this paper
• Pak Heart J

  2015cites this paper
• Thyroid-stimulating hormone concentration as an independent risk factor of venous thromboembolism regardless of thyroid function.

  2015cites this paper
• History of thyroid disorders in relation to clinical outcomes in atrial fibrillation.

  2015cites this paper
• Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the Tromsø study.

  2015cites this paper
• Hemostatic Disorders in Hormonally Active Pituitary Tumors

  2015cites this paper
• Utility of plasma fibrinogen in the differential diagnosis of thyrotoxicosis.

  2015cites this paper
• Mean platelet volume is significantly associated with serum levels of thyroid-stimulating hormone in a cohort of older euthyroid subjects

  2015cites this paper
• Recurrent deep vein thrombosis presenting in a patient with overt hyperthyroidism

  2014cites this paper
• Unexpected causes of pulmonary hypertension in a previously healthy Thai rural man with right-sided heart failure

  2014cites this paper
• Plateletcrit

  2014cites this paper
• The Association between Platelet Count and Acute Phase Response in Chronic Spontaneous Urticaria

  2014cites this paper
• The effect of thyroid hormone on haemostasis and thrombosis

  2014cites this paper
• High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study

  2014cites this paper
• Different patterns of fibrinolytic abnormalities and lipid profile in hypothyroid and hyperthyroid patients

  2014cites this paper
• [Thyroid dysfunction and the hemostatic system].

  2014cites this paper
• Relationship between placental grade and mean platelet volume

  2014cites this paper
• Association of vWA and TPOX Polymorphisms with Venous Thrombosis in Mexican Mestizos

  2014cites this paper
• Hyperthyroidism: A rare cause of pulmonary embolism: Report of two cases

  2013influential citation
• Original Article Effect of levothyroxine on the fibrinolytic system, lipid profile, and plasma glucose in rats

  2013cites this paper
• The Changes in the Endothelial Function and Haemostatic and Inflammatory Parameters in Subclinical and Overt Hyperthyroidism

  2013cites this paper
• Iatrogenic venous thrombosis secondary to supplemental medicine toxicity

  2013cites this paper
• Subclinical Hyperthyroidism and Cardiovascular Risk: Recommendations for Treatment

  2013cites this paper
• ACUTE MYOCARDIAL INFARCTION ASSOCIATED WITH THYROTOXICOSIS

  2013cites this paper
• Von Willebrand Factor: A Novel Marker of Endothelial Dysfunction in Clinical Hyperthyroidism Patients

  2013cites this paper
• A study of venous thrombosis incidence in patients with acute hyperthyroidism

  2013cites this paper
• The incidence of venous thromboembolism in patients with overt hyperthyroidism

  2012cites this paper
• Obesity and Weight Loss: The Influence of Thyroid Hormone on Adipokines

  2012cites this paper
• Effect of thyroxine on fibrinolytic system in rat.

  2012cites this paper
• Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia

  2012influential citation
• Increased Thrombin-Activatable Fibrinolysis Inhibitor and Decreased Tissue Factor Pathway Inhibitor and Thrombomodulin Levels in Children with Hypothyroidism

  2012cites this paper
• Increased levels of free thyroxine and risk of venous thrombosis in a large population‐based prospective study

  2012cites this paper
• Overt and Mild Subclinical Hypothyroidism Do Not Influence Mean Platelet Volume in Premenopausal Women Having Low Cardiac Risk

  2012cites this paper
• The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors

  2012cites this paper
• A case of myocardial infarction in a young female with subclinical hyperthyroidism.

  2012cites this paper
• Cerebral sinus venous thrombosis in a child with hyperthyroidism

  2012cites this paper
• Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.

  2012cites this paper
• The hormonal influence on the haemostatic system and the risk of thrombosis

  2012cites this paper
• Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature.

  2011cites this paper
• Thyroid hormonal axis regulates protein C anticoagulation pathway in rats

  2011cites this paper
• Transient ST-segment elevation due to iatrogenic hyperthyroidism in a patient with normal coronary arteries.

  2011cites this paper
• Hyperthyroidism and Venous Thrombosis: A Casual or Causal Association? A Systematic Literature Review

  2011cites this paper
• Thyroid disorders and hypercoagulability.

  2011cites this paper
• Hormones of hypothalamic-pituitary-thyroid axis are significant regulators of synthesis and secretion of vitamin K-dependent plasma coagulation factors.

  2011cites this paper